Genetic tests to detect cancer are feasible. But with researchers drowning in a sea of biomarkers and little financial incentive to get the tests on the shelves, the idea is floundering. Virginia Gewin reports.
This is a preview of subscription content, log in via an institution to check access.
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Gewin, V. Missing the mark. Nature 449, 770–771 (2007). https://doi.org/10.1038/449770a
Published:
Issue Date:
DOI: https://doi.org/10.1038/449770a
- Springer Nature Limited